相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Value of Fast MVO Identification From Contrast-Enhanced Cine (CE-SSFP) Combined With Myocardial Strain in Predicting Adverse Events in Patients After ST-Elevation Myocardial Infarction
Min Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
2021 ESC/EACTS Guidelines for the management of valvular heart disease Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Alec Vahanian et al.
EUROPEAN HEART JOURNAL (2022)
Cardiac Biomarkers and Prediction of Early Outcome After Heart Valve Surgery: A Prospective Observational Study
Aaron Wozolek et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)
B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Toshio Nishikimi et al.
BIOLOGY-BASEL (2022)
Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery
Dipal M. Patel et al.
AMERICAN HEART JOURNAL (2020)
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T
Alberto Aimo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
Sandra Crnko et al.
ESC HEART FAILURE (2020)
Soluble ST2: A complex and diverse role in several diseases
Evgenija Homsak et al.
CLINICA CHIMICA ACTA (2020)
BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Zhipeng Cao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure
Xavier Charmetant et al.
CLINICAL NEPHROLOGY (2019)
Using Soluble ST2 to Predict Adverse Postoperative Outcomes in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Surgery
Ahmet Dolapoglu et al.
MEDICINA-LITHUANIA (2019)
sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting
Meagan E. Stabler et al.
BIOMARKERS (2019)
Soluble ST2 in Heart Failure
Cian P. McCarthy et al.
HEART FAILURE CLINICS (2018)
Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease
Mohammed Laqqan et al.
PLOS ONE (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Volkmar Falk et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)
ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
Johannes Schmid et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
JOURNAL OF CARDIAC FAILURE (2017)
Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015
David A. Watkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective
William S. Jenkins et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Outcome of cardiac surgery in patients with low preoperative ejection fraction
Marina Pieri et al.
BMC ANESTHESIOLOGY (2016)
Clinical Impact of Changes in Left Ventricular Function After Aortic Valve Replacement Analysis From 3112 Patients
Dai Une et al.
CIRCULATION (2015)
The IL-33/ST2 axis: Role in health and disease
Marjorie De la Fuente et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Prognostic Value of Soluble ST2 in the Valsartan Heart Failure Trial
Inder S. Anand et al.
CIRCULATION-HEART FAILURE (2014)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
John Gordon Harold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian et al.
EUROPEAN HEART JOURNAL (2012)
Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction
Robin A. P. Weir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)